arXivDaily arXiv每日学术速递 周一至周五更新
arXiv 1602.07614cs.LG
收藏

一个有效推断癌症克隆进化的选择优势模型

A Model of Selective Advantage for the Efficient Inference of Cancer Clonal Evolution

University of Milano Bicocca(米兰比可卡大学)

Daniele Ramazzotti

摘要:

最近,人们对从基因组数据推断癌症进展的严格算法重新产生了兴趣。动机是多方面的:(i)来自癌症患者的NGS和单细胞数据不断增长,(ii)需要新的数据科学和机器学习算法来推断癌症进展的模型,以及(iii)希望了解肿瘤的时间和异质结构,以通过有效的治疗干预来驯服其进展。这篇论文提出了一个多学科的努力来模拟肿瘤的进展,涉及遗传改变的连续积累,每个产生的人口表现出自己的癌症表型。在这项工作中提出的框架以及从它衍生的算法,代表了一种新的方法来推断癌症的进展,其准确性和收敛速度超过现有的技术。这种方法的力量来自几个领域,包括机器学习算法、因果关系理论和癌症生物学。此外,提出了一种从测序的癌症基因组中提取整体水平进展模型的模块化管道。该管道结合了最先进的技术,用于样本分层,驱动程序选择,识别健身等效的独家变更和进展模型推理。此外,结果通过具有现实生成模型的合成数据进行验证,并在真实癌症数据集的背景下进行经验解释;在后一种情况下,还突出显示了具有生物学意义的结论。具体来说,它证明了管道再现大部分结直肠癌知识的能力,以及提出新假设的能力。最后,它也证明了所提出的框架可以应用于重建单个患者的癌症克隆的进化历史,如透明细胞肾癌的例子所示。

英文摘要:

Recently, there has been a resurgence of interest in rigorous algorithms for the inference of cancer progression from genomic data. The motivations are manifold: (i) growing NGS and single cell data from cancer patients, (ii) need for novel Data Science and Machine Learning algorithms to infer models of cancer progression, and (iii) a desire to understand the temporal and heterogeneous structure of tumor to tame its progression by efficacious therapeutic intervention. This thesis presents a multi-disciplinary effort to model tumor progression involving successive accumulation of genetic alterations, each resulting populations manifesting themselves in a cancer phenotype. The framework presented in this work along with algorithms derived from it, represents a novel approach for inferring cancer progression, whose accuracy and convergence rates surpass the existing techniques. The approach derives its power from several fields including algorithms in machine learning, theory of causality and cancer biology. Furthermore, a modular pipeline to extract ensemble-level progression models from sequenced cancer genomes is proposed. The pipeline combines state-of-the-art techniques for sample stratification, driver selection, identification of fitness-equivalent exclusive alterations and progression model inference. Furthermore, the results are validated by synthetic data with realistic generative models, and empirically interpreted in the context of real cancer datasets; in the later case, biologically significant conclusions are also highlighted. Specifically, it demonstrates the pipeline's ability to reproduce much of the knowledge on colorectal cancer, as well as to suggest novel hypotheses. Lastly, it also proves that the proposed framework can be applied to reconstruct the evolutionary history of cancer clones in single patients, as illustrated by an example from clear cell renal carcinomas.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑